Human genetic variation recognizes functional elements in noncoding sequence

Genome Research

Volumn 20, Issue 3, 2010, Pages 311-319

  Lomelin, David ^a   Jorgenson, Eric ^a,b   Risch, Neil ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA;

ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; ENHANCER REGION; ETHNICITY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC DATABASE; GENETIC VARIABILITY; HUMAN; HUMAN EXPERIMENT; HUMAN GENETICS; INTRON; INTRONIC SPLICING ENHANCER; PRIORITY JOURNAL; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; UNTRANSLATED REGION;

BASE SEQUENCE; COMPUTATIONAL BIOLOGY; DNA; GENETIC VARIATION; GENOME, HUMAN; HUMANS; INTRONS; POLYMORPHISM, GENETIC; RNA PRECURSORS; RNA SPLICING;

EID: 77649267541     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.094151.109     Document Type: Article

References (56)

1. Abril JF, Castelo R, Guigo R. 2004. Comparison of splice sites in mammals and chicken. Genome Res 15: 111-119.
2. Ast G, Pavelitz T, Weiner AM. 2001. Sequences upstream of the branch site are required to form helix II between U2 and U6 snRNA in a trans-splicing reaction. Nucleic Acids Res 29: 1741-1749.
3. Burrows NP, Nicholls AC, Richards AJ, Luccarini C, Harrison JB, Yates JRW, Pope FM. 1998. A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families. Am J Hum Genet 63: 390-398.
4. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, et al. 1999. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22: 231-238.
5. Cartegni L, Chew SL, Krainer AR. 2002. Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat Rev Genet 3: 285-298.
6. Chamary JV, Parmley JL, Hurst LD. 2006. Hearing silence: Non-neutral evolution at synonymous sites in mammals. Nat Rev Genet 7: 98-108.
7. Crawford DC, Carlson CS, Rieder MJ, Carrington DP, Yi Q, Smith JD, Eberle MA, Kruglyak L, Nickerson DA. 2004. Haplotype diversity across 100 candidate genes for inflammation, lipid metabolism, and blood pressure regulation in two populations. Am J Hum Genet 74: 610-622.
8. Easton DF, Pooley KA, Dunning AM, Pharoah PDP, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, et al. 2007. Genomewide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093.
9. Freimer NB, Sabatti C. 2007. Human genetics: Variants in common diseases. Nature 445: 828-830.
10. Gozani O, Potashkin J, Reed R. 1998. A potential role for U2AF-SAP 155 interactions in recruiting U2 snRNP to the branch site. Mol Cell Biol 18: 4752-4760.
11. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, Cooper R, Lipshutz R, Chakravarti A. 1999. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nature 22: 239-247.
12. Hamlington JD, Clough MV, Dunston JA, McIntosh I. 2000. Deletion of a branch-point consensus sequence in the LMX1B gene causes exon skipping in a family with nail patella syndrome. Eur J Hum Genet 8: 311-314.
13. Harmuth K, Barta A. 1988. Unusual branch point selection in processing of human growth hormone pre-mRNA. Mol Cell Biol 8: 2011-2020.
14. Hartl DL, Clark AG. 1997. Principles of population genetics, 3rd ed., pp. 37-69. Sinauer, Sunderland, MA.
15. Hornig H, Aebi M, Weissmann C. 1986. Effect of mutations at the lariat branch acceptor site on β-globin pre-mRNA splicing in vitro. Nature 324: 589-591.
16. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE,Wacholder S, Wang Z, Welch R, Hutchinson A, et al. 2007. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39: 870-874.
17. Janssen RJ, Wevers RA, Haussler M, Luyten JA, Steenbergen-Spanjers GC, Hoffman GF, Nagatsu T, Van Den Heuvel LP. 2000. A branch site mutation leading to aberrant splicing of the human tyrosine hydroxylase gene in a child with a severe extrapyramidal movement disorder. Ann Hum Genet 64: 375-382.
18. Khan SG, Metin A, Gozukara E, Inui H, Shahlavi T, Muniz-Medina V, Baker CC, Ueda T, Aiken JR, Schneider TD, et al. 2004. Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: Mutations result in reduced XPC mRNA levels that correlate with cancer risk. Hum Mol Genet 13: 343-352.
19. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MM. 2007. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315: 525-528.
20. Kol G, Galit L, Ast G. 2005. Human-mouse comparative analysis reveals that branch-site plasticity contributes to splicing regulation. Hum Mol Genet 14: 1559-1568.
21. Kralovicova J, Houngninou-Molango S, Kramer A, Vorechovsky I. 2004. Branch site haplotyoes that control alternative splicing. Hum Mol Genet 13: 3189-3202.
22. Kramer A. 1996. The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu Rev Biochem 65: 367-409.
23. Kuivenhoven JA,Weibusch H, Pritchard PH, Funke H, Benne R, Assmann G, Kastelein JP. 1996. An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease). J Clin Invest 98: 358-364.
24. Langford CJ, Klinz F, Donath C, Gallwitz D. 1984. Point mutations identify the conserved, intron-contained TACTAAC box as an essential splicing signal sequence in yeast. Cell 36: 645-653.
25. Leabman MK, Huang CC, DeYoung J, Carlson EJ, Taylor TR, de la Cruz M, Johns SJ, Stryke D, KawamotoM, Urban TJ, et al. 2003. Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci 100: 5896-5901.
26. Lew JM, Fei YL, Aleck K, Blencowe BJ, Weksberg R, Sadowski PD. 2004. CDKN1C mutation inWiedemann-Beckwith syndrome patients reduce RNA splicing efficiency and identifies a splicing enhancer. Am J Med Genet 127A: 268-276.
27. Livingston RJ, von Niederhausern A, Jegga AG, Crawford DC, Carlson CS, Rieder MJ, Gowrisankar S, Aronow BJ, Weiss RB, Nickerson DA. 2004. Pattern of sequence variation across 213 environmental response genes. Genome Res 14: 1821-1831.
28. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell JE. 2000. Molecular cell biology, 4th ed. Freeman, New York.
29. Matlin AJ, Clark F, Smith CWJ. 2005. Understanding alternative splicing: Towards a cellular code. Nature 6: 386-398.
30. Matsushima M, Kobayashi K, EmiM, Saito H, Saito J, Suzumori K, Nakamura Y. 1995. Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: Four germline mutations, but no evidence of somatic mutation. Hum Mol Genet 4: 1953-1956.
31. McCarthy EMS, Phillips JA. 1998. Characterization of an intron splice enhancer that regulates alternative splicing of human GH pre-mRNA. Hum Mol Genet 7: 1491-1496.
32. McCullough AJ, Berget SM. 1997. G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection. Mol Cell Biol 17: 4562-4571.
33. Myrick A, Sarr O, Dieng T, Ndir O, Mboup S,Wirth DF. 2005. Analysis of the genetic diversity of the Plasmodium falciparum multidrug resistance gene 5′ upstream region. Am J Trop Med Hyg 72: 182-188.
34. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, Maixner W, Diatchenko L. 2006. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314: 1930-1933.
35. Padgett RA, KonarskaMM, Aebi M, Hornig H,Weissmann C, Sharp PA. 1985. Nonconsensus branch-site sequences in the in vitro splicing of transcripts of mutant rabbit β-globin genes. Proc Natl Acad Sci 82: 8349-8353.
36. Query CC, McCaw PS, Sharp PP. 1997. A minimal spliceosomal complex A recognizes the branch site and polypyrimidine tract. Mol Cell Biol 17: 2944-2953.
37. Reed R, Maniatis T. 1985. Intron sequences involved in lariat formation during pre-mRNA splicing. Cell 41: 95-105.
38. Risch NJ. 2000. Searching for genetic determinants in the new millennium. Nature 405: 847-856.
39. Ruskin B, Krainer AR, Maniatis T, Green MR. 1984. Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro. Cell 38: 317-331.
40. Ruskin B, Greene JM, Green MR. 1985. Cryptic branch point activation allows accurate in vitro splicing of human β-globin intron mutants. Cell 41: 833-844.
41. Schneider JA, Pungliya MS, Choi JY, Jiang R, Sun XJ, Salisbury BA, Stephens JC. 2003. DNA variability of human genes. Mech Ageing Dev 124: 17-25.
42. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU, et al. 2007. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316: 1341-1345.
43. Seth P, Miller HB, Lasda EL, Pearson JL, Garcia-Blanco MA. 2008. Identification of an intronic splicing enhancer essential for the inclusion of FGFR2 exon IIIc. J Biol Chem 283: 10058-10067.
44. Staley JP, Guthrie C. 1998. Mechanical devices of the spliceosome: Motors, clocks, springs, and things. Cell 92: 315-326.
45. Stryke D, Huang CC, Kawamoto M, Johns SJ, Carlson EJ, Deyoung JA, Leabman MK, Herskowitz I, Giacomini KM, Ferrin TE. 2003. SNP analysis and presentation in the pharmacogenetics of membrane transporters project. Pac Symp Biocomput 8: 535-547.
46. Tajima F. 1989. Statistical methods to test for nucleotide mutation hypothesis by DNA polymorphism. Genetics 123: 585-595.
47. Urban TJ, Sebro R, Hurowitz EH, Leabman MK, Badagnani I, Lagpacan LL, Risch N, Giacomini KM. 2006. Functional genomics of membrane transporters in human populations. Genome Res 16: 223-230.
48. Vijayraghavan U, Parker R, Tamm J, Iimura Y, Rossi J, Abelson J, Guthrie C. 1986. Mutations in conserved intron sequences affect multiple steps in the yeast splicing pathway, particularly assembly of the spliceosome. EMBO J 5: 1683-1695.
49. Vivenza D, Guazzarotti L, Godi M, Frasca D, di Natale B, Momigliano-Richiardi P, Bona G, Giordano M. 2006. A novel deletion in the GH1 gene including the IVS3 branch site responsible for autosomal dominant isolated growth hormone deficiency. J Clin Endocrinol Metab 91: 980-986.
50. Vuillaumier-Barrot S, Le Bizec C, De Lonlay P, Madinier-Chappat N, Barnier A, Dupré T, Durand G, Seta N. 2006. PMM2 intronic branch-site mutations in CDG-Ia. Mol Genet Metab 87: 337-340.
51. Wang J, Smith PJ, Krainer AR, Zhang MQ. 2005. Distribution of SR protein exonic splicing enhancer motifs in human protein-coding genes. Nucleic Acids Res 33: 5053-5062.
52. Webb JC, Patel DD, Shoulders CC, Knight BL, Soutar AK. 1996. Genetic variation at a splicing branch point in intron 9 of the low density lipprotein (LDL)-receptor gene: A rare mutation that disrupts mRNA splicing in a patient with familiar hypercholesterolaemia and a common polymorphism. Hum Mol Genet 5: 1325-1331.
53. Wu S, Romfo CM, Nilsen TW, Green MR. 1999. Functional recognition of the 3′ splice site AG by the splicing factor U2AF35. Nature 402: 832-835.
54. Yeo G, Hoon S, Venkatesh B, Burge CB. 2004. Variation in sequence and organization of splicing regulatory elements in vertebrate genes. Proc Natl Acad Sci 101: 15700-15705.
55. 1061(-1)G→C]. Atherosclerosis 146: 125-131.
56. Zeitlin S, Efstratiadis A. 1984. In vivo splicing products of the rabbit β-globin pre-mRNA. Cell 39: 589-602.